Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleOncology

Immune Modulation Therapy and Imaging: Workshop Report

Anthony F. Shields, Paula M. Jacobs, Mario Sznol, Michael M. Graham, Ron N. Germain, Lawrence G. Lum, Elizabeth M. Jaffee, Elisabeth G.E. de Vries, Sridhar Nimmagadda, Annick D. Van den Abbeele, David K. Leung, Anna M. Wu, Elad Sharon and Lalitha K. Shankar
Journal of Nuclear Medicine March 2018, 59 (3) 410-417; DOI: https://doi.org/10.2967/jnumed.117.195610
Anthony F. Shields
1Karmanos Cancer Institute, Wayne State University, Detroit, Michigan
2National Cancer Institute, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paula M. Jacobs
2National Cancer Institute, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mario Sznol
3Yale University, New Haven, Connecticut
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael M. Graham
4University of Iowa, Iowa City, Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ron N. Germain
2National Cancer Institute, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lawrence G. Lum
5University of Virginia, Charlottesville, Virginia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth M. Jaffee
6Johns Hopkins University, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisabeth G.E. de Vries
7University of Groningen Medical Center, Groningen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sridhar Nimmagadda
6Johns Hopkins University, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annick D. Van den Abbeele
8Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David K. Leung
9Bristol-Myers Squibb, Princeton, New Jersey; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna M. Wu
10Crump Institute for Molecular Imaging, David Geffen School of Medicine at UCLA, Los Angeles, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elad Sharon
2National Cancer Institute, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lalitha K. Shankar
2National Cancer Institute, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Data supplements

  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 59 (3)
Journal of Nuclear Medicine
Vol. 59, Issue 3
March 1, 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Immune Modulation Therapy and Imaging: Workshop Report
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Immune Modulation Therapy and Imaging: Workshop Report
Anthony F. Shields, Paula M. Jacobs, Mario Sznol, Michael M. Graham, Ron N. Germain, Lawrence G. Lum, Elizabeth M. Jaffee, Elisabeth G.E. de Vries, Sridhar Nimmagadda, Annick D. Van den Abbeele, David K. Leung, Anna M. Wu, Elad Sharon, Lalitha K. Shankar
Journal of Nuclear Medicine Mar 2018, 59 (3) 410-417; DOI: 10.2967/jnumed.117.195610

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Immune Modulation Therapy and Imaging: Workshop Report
Anthony F. Shields, Paula M. Jacobs, Mario Sznol, Michael M. Graham, Ron N. Germain, Lawrence G. Lum, Elizabeth M. Jaffee, Elisabeth G.E. de Vries, Sridhar Nimmagadda, Annick D. Van den Abbeele, David K. Leung, Anna M. Wu, Elad Sharon, Lalitha K. Shankar
Journal of Nuclear Medicine Mar 2018, 59 (3) 410-417; DOI: 10.2967/jnumed.117.195610
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • IMMUNOLOGY OVERVIEW AND CURRENT ROLE OF IMAGING
    • T-CELL THERAPIES
    • VACCINE THERAPY
    • CLARIFYING RESPONSE CRITERIA
    • IMAGING CAPABILITIES
    • BIOMARKERS OF IMMUNE MODULATION
    • IMAGING INFLAMMATION WITH 18F-FDG, 18F-FLT, AND BEYOND
    • ANTIBODY IMMUNOTHERAPY IMAGING
    • LABELED ANTIBODY FRAGMENTS FOR IMAGING
    • IMAGING WITH CHEMOKINES AND SMALL MOLECULES
    • BRIDGING THE GAPS TO INVESTIGATIONAL-NEW-DRUG AND NCI SUPPORT
    • NEXT STEPS
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology

  • Rediscovering the indispensable role of FDG PET in kidney cancer imaging
  • The role of FDG PET/CT in clinical evaluation and management of nasopharyngeal carcinoma
  • Immune-related adverse events on 18F-FDG PET/CT in patients undergoing immune checkpoint inhibitor therapy
Show more Oncology

Clinical

  • TauIQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans
  • Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
  • Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
Show more Clinical

Similar Articles

Keywords

  • immunotherapy
  • biomarkers
  • imaging cancer
SNMMI

© 2025 SNMMI

Powered by HighWire